Results
1 -
10 of
14Multi-kinase inhibitors, AURKs and cancer, Medical Oncology Aurora Kinases and Their Inhibitors: More Than One Target and One Drug, Targeted Therapies in Cancer The Clinical Development of Aurora Kinase Inhibitors in Acute Myeloid Leukemia, Targeted Therapy of Acute Myeloid Leukemia Danusertib (formerly PHA-739358) u2013 A Novel Combined Pan-Aurora Kinases and Third Generation Bcr-Abl Tyrosine Kinase Inhibitor, Small Molecules in Oncology Target Validation and Biomarker Identification in Oncology, Molecular Diagnosis & Therapy Mitotic driversu2014inhibitors of the Aurora B Kinase, Cancer and Metastasis Reviews Phase 1 dose escalation trial of ilorasertib, a dual Aurora/VEGF receptor kinase inhibitor, in patients with hematologic malignancies, Investigational New Drugs RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia, Leukemia Treatment of human pre-B acute lymphoblastic leukemia with the Aurora kinase inhibitor PHA-739358 (Danusertib), Molecular Cancer